SEC Form 4 · accession 0001209191-15-083321
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alejandra Carvajal
Officer — VP, General Counsel
Period of report
Dec 1, 2015
Accepted (ET)
Dec 3, 2015 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $3.29 | Dec 1, 2015 | A | 158,000 | A | — | Nov 30, 2024 | Common Stock | 158,000 | 158,000 | D |
Explanation of responses
- F1The shares underlying this option vest in three equal installments on December 1, 2016, December 1, 2017 and December 1, 2018, respectively, subject to Ms. Carvajal's continued service.